Clinical Trials · NCT00630695
Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University Hospital, Limoges
- Enrollment
- 148
- Start date
- Mar 2008
- Locations
- 1 site, France
- Primary endpoint
- Quantity of lymph collected by the drain